DANIEL MUSHER to Antiretroviral Therapy, Highly Active
This is a "connection" page, showing publications DANIEL MUSHER has written about Antiretroviral Therapy, Highly Active.
Connection Strength
0.205
-
The lack of therapeutic benefit of adding hydroxyurea to highly active antiretroviral therapy (HAART). J Acquir Immune Defic Syndr. 2002 Jul 01; 30(3):363-4.
Score: 0.181
-
Response of human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy to vaccination with 23-valent pneumococcal polysaccharide vaccine. Clin Infect Dis. 2003 Aug 01; 37(3):438-47.
Score: 0.012
-
Safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-1 infected former drug users. Vaccine. 2002 Nov 01; 20(31-32):3720-4.
Score: 0.012